CA 19-9 in Pancreatic Cancer
- 1 January 1998
- journal article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 7 (1), 93-101
- https://doi.org/10.1016/s1055-3207(18)30286-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Elevated Tumor-Associated Antigen CA 19-9 in a Patient With an Enlarged PancreasSouthern Medical Journal, 1997
- Tumor markers in patients with pancreatic carcinomaCancer, 1996
- Comparison of Preoperative Serum CA19-9 Levels with Results of Diagnostic Imaging Modalities in Patients Undergoing Laparotomy for Suspected Pancreatic or Gallbladder DiseasePancreas, 1994
- Prognostic Values of Preoperative and Postoperative CEA and CA19.9 Levels in Pancreatic CancerPancreas, 1994
- Diagnosis of Pancreatic Cancer and Prediction of Unresectability Using the Tumor-Associated Antigen CA19-9Pancreas, 1994
- A Diagnostic Approach to Pancreatic CancerDigestive Diseases, 1994
- Clinical Utility of the Serum CA 19-9 Test for Diagnosing Pancreatic Carcinoma in Symptomatic PatientsPancreas, 1992
- Prognostic Value of Serum CA 19–9 Levels in Pancreatic AdenocarcinomaAnnals of Surgery, 1992
- Diagnosis of Pancreatic CarcinomaPancreas, 1992
- Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bankInternational Journal of Cancer, 1984